Pioneering Melanoma Expert Dies at 59 After Self-Experimented Brain Cancer Therapy
TL;DR Summary
Renowned melanoma pathologist Richard Scolyer, named Australian of the Year in 2024, died at 59 from a grade‑4 brain cancer (glioblastoma) after he and colleague Georgina Long pursued a bold, self‑initiated immunotherapy approach. The treatment combined immune drugs and a personalized vaccine, with early brain tissue showing increased immune activity and a case report later published in Nature Medicine (2025). The effort has spurred ongoing research and a new clinical trial at Duke University.
- Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituary The Guardian
- Richard Scolyer: Australian doctor who underwent world-first brain tumour treatment dies BBC
- What is glioblastoma and why is it so hard to treat? Australian Broadcasting Corporation
- Richard Scolyer, pathologist who was his own guinea pig as he fought brain cancer – obituary The Telegraph
- Matt Dun: Remembering the Legacy of Prof Richard Scolyer Oncodaily
Reading Insights
Total Reads
0
Unique Readers
33
Time Saved
5 min
vs 6 min read
Condensed
93%
1,004 → 74 words
Want the full story? Read the original article
Read on The Guardian